Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/13/2006 | EP0979276B1 Complement receptor type 1 (cr1)-like sequences |
12/13/2006 | EP0973914B1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use |
12/13/2006 | EP0968284B1 An improved method for the production and purification of adenoviral vectors |
12/13/2006 | EP0883343B1 Compositions for treating ischemic tissue |
12/13/2006 | EP0875251B1 Therapeutic agent for treatment of fiv infections |
12/13/2006 | EP0854885B1 Recombinant anti-cd4 antibodies for human therapy |
12/13/2006 | EP0809695B1 Transcription factor - e2f-5 |
12/13/2006 | EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
12/13/2006 | EP0651805B1 Method of intracellular binding of target molecules |
12/13/2006 | CN1878871A IL-1 receptor based antagonists and methods of making and using |
12/13/2006 | CN1878867A Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
12/13/2006 | CN1878791A 合成的抗微生物多肽 Synthetic antimicrobial polypeptides |
12/13/2006 | CN1878789A Human cathelicidin antimicrobial peptides |
12/13/2006 | CN1878570A Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
12/13/2006 | CN1878565A Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
12/13/2006 | CN1878564A Glutamine for use in treating injury |
12/13/2006 | CN1878563A Pharmaceutical compositions including low dosages of desmopressin |
12/13/2006 | CN1878562A Antybody therapy |
12/13/2006 | CN1878555A Combination comprising n-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate |
12/13/2006 | CN1878545A Thyroid hormone analogs and methods of use |
12/13/2006 | CN1878541A Microparticles comprising somatostatin analogues |
12/13/2006 | CN1878529A Combined cosmetic or therapeutic preparation |
12/13/2006 | CN1876833A Anti-hiv agent evaluation method |
12/13/2006 | CN1876826A Production and amplification method for recombinant protein medicine by ammonia salt forced fermentation |
12/13/2006 | CN1876825A Enzyme-hydrolyzed polypeptide of ostrich blood and physiological activity thereof |
12/13/2006 | CN1876796A Vigorous wine and preparation method thereof |
12/13/2006 | CN1876684A A series of polypeptide capable of blocking IL-6 and its medicinal uses |
12/13/2006 | CN1876683A Human antibodies that bind human TNFalpha |
12/13/2006 | CN1876682A Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method |
12/13/2006 | CN1876681A Cancer-suppressing protein and its gene and uses |
12/13/2006 | CN1876680A Recombinant solenopsis invicta sensitized toxin protein and its uses |
12/13/2006 | CN1876678A Retroviral resistant polypeptide and its preparing method |
12/13/2006 | CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof |
12/13/2006 | CN1876676A Antineoplastic oligopeptide and its preparation method and application |
12/13/2006 | CN1876186A Endostatin conjugate and its preparation method |
12/13/2006 | CN1876178A Granule with beauty and health function |
12/13/2006 | CN1876177A Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
12/13/2006 | CN1876176A Omega-conotoxin M VII A mutant and its preparation and uses |
12/13/2006 | CN1876175A Neurotrophic factor slow release nanometer formulation and its preparation method and uses |
12/13/2006 | CN1876174A Pharmaceutical combination containing kuhseng element and thymus pentapeptide and preparation method thereof |
12/13/2006 | CN1876173A Thymus pentapeptide slow-release microshpere formulation for injection and its preparation method |
12/13/2006 | CN1875992A Enzymolysis peptide of locust and its physiological activity |
12/13/2006 | CN1875988A Method for preparing low molecular weighted glucidamin collagen composition, its product and use |
12/13/2006 | CN1875748A Application method of lactoferritin in food |
12/13/2006 | CN1289678C Production and use of high expression, high purity, high activity gene recombinant human lysozyme |
12/13/2006 | CN1289673C Anemone neurotoxin gene Sr6 and application thereof |
12/13/2006 | CN1289672C Hippocampus protease inhibitor gene and its use |
12/13/2006 | CN1289670C Polynucleotide useful for modulating cancer cell proliferation |
12/13/2006 | CN1289528C Recombinant human interferon-alpha 1b compound and process for preparation |
12/13/2006 | CN1289527C Horny cell growth factor mutant with high bioactivity and its preparation process and use thereof |
12/13/2006 | CN1289526C Stem cell factor |
12/13/2006 | CN1289524C Human telomerase active inhibitor protein and use thereof |
12/13/2006 | CN1289521C Anagonism peptide of tumor necrosis factor and its application |
12/13/2006 | CN1289466C Pharmaceutical compounds |
12/13/2006 | CN1289145C Application of plasminogen in preparing topical pharmaceutical composition for promoting tympanic membrane perforation in mammal |
12/13/2006 | CN1289144C Medicine for treating radioactive membrana mucosa damage, repeative aphtha and paradentitis |
12/13/2006 | CN1289143C Method for reducing decreasing blood-glucose and delaying weight increase of diabetic |
12/13/2006 | CN1289142C Medicinal new dosage form containing SA liposome as medicine carrier |
12/13/2006 | CN1289141C Thrombogenesis inhibiting medicine |
12/13/2006 | CN1289140C Use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
12/13/2006 | CN1289098C Vesicular stromatitis virus (VSV) |
12/13/2006 | CN1289082C Medicine composition for treating diabetes |
12/13/2006 | CN1289066C Glicetin -1 slow release microspheric preparation and its use |
12/13/2006 | CN1289061C Medicine for preventing and treating bromidrosis |
12/12/2006 | US7149304 Personal communication center performance display and status alert system |
12/12/2006 | US7148404 Antimicrobial polypeptides |
12/12/2006 | US7148399 Coffee mannanase |
12/12/2006 | US7148378 Analgesics; neuropathic pain; bipolar disorders |
12/12/2006 | US7148359 Protease inhibitors; viricides; purity, crystal structure |
12/12/2006 | US7148346 Feeding the feedstock into an extraction column under conditions adapted for separating more- or less-polar impurities from feedstock, lighter phase flows counter to a heavier phase; product is a cyclosporin, a rapamycin |
12/12/2006 | US7148342 Compositions and methods for sirna inhibition of angiogenesis |
12/12/2006 | US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors |
12/12/2006 | US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors |
12/12/2006 | US7148333 Stabilization; administering by injection |
12/12/2006 | US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal |
12/12/2006 | US7148328 Compositions and methods for regulating autolytic processes in bacteria |
12/12/2006 | US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
12/12/2006 | US7148322 Process for the preparation of echinocandin derivatives |
12/12/2006 | US7148260 Water-based emulsifier wax gels including free sphingoid bases and oil in-water emulsion including the same |
12/12/2006 | US7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid |
12/12/2006 | US7148233 Treatment of cardiovascular and related pathologies |
12/12/2006 | US7148209 Repairing tissues in humans or animals using blood and tissue dependent polymer gels |
12/12/2006 | US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein |
12/12/2006 | US7148201 Use of human plasma hyaluronidase in cancer treatment |
12/12/2006 | US7148199 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
12/12/2006 | US7148198 Antibacterial agents |
12/12/2006 | US7148197 Orally administered small peptides synergize statin activity |
12/12/2006 | US7148196 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine |
12/12/2006 | US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer |
12/12/2006 | US7148194 peptide agents to prevent and to treat skin-related conditions, such as wrinkles |
12/12/2006 | US7148193 Polypeptides for binding hormone receptors for detection of growth receptors for cattle or humans |
12/12/2006 | US7148192 Neuroprotective dietary supplement |
12/12/2006 | US7148191 Antigenic composition |
12/12/2006 | US7148190 Haptotactic peprides |
12/12/2006 | US7148062 Method for generating primate trophoblasts |
12/12/2006 | US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation |
12/12/2006 | US7148048 Elution through a chromatography column, using a hydroxyapatite column; biological injection, treating genetic disorders |
12/12/2006 | US7148044 Nucleic acid enzyme for RNA cleavage |
12/12/2006 | US7148039 Protein derived composition for skin care using spider silk protein or an analog with adjuvants |
12/12/2006 | US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |